Venture philanthropy has the power to drive social change, have profound social impact and address and solve social needs. It is a high-engagement and long-term approach whereby an investor for impact supports a social purpose organization. The practice of defining your philanthropic asset, which is what you give to charity as an investment is the basis of venture philanthropy.
What does all this mean and how can it be leveraged to maximize impact and reach?
Featuring:
Dave Doneson, CEO at The American Committee of the Weizmann Institute of Science
Anna Turetsky, Ph.D., principal, Mark Foundation for Cancer Research
Dave Greenwald, Ph.D., Deerfield Management
Rusty Kelley, The Foundation for Fighting Blindness
Brought to you by Cure by Deerfield
The Cure at 345 Park Avenue South, leading life science, digital health, and tech-enabled companies from across the world come together to uncover cutting-edge solutions for those in need. We provide laboratories, engineering and computing space, and other amenities and supportive services to help today’s thought leaders build a better tomorrow.